CN1079236C - 含阴离子交换树脂的片剂 - Google Patents

含阴离子交换树脂的片剂 Download PDF

Info

Publication number
CN1079236C
CN1079236C CN96195992A CN96195992A CN1079236C CN 1079236 C CN1079236 C CN 1079236C CN 96195992 A CN96195992 A CN 96195992A CN 96195992 A CN96195992 A CN 96195992A CN 1079236 C CN1079236 C CN 1079236C
Authority
CN
China
Prior art keywords
tablet
exchange resin
anion exchange
carbon atoms
crystalline cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96195992A
Other languages
English (en)
Chinese (zh)
Other versions
CN1192150A (zh
Inventor
后藤武
目野龙也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of CN1192150A publication Critical patent/CN1192150A/zh
Application granted granted Critical
Publication of CN1079236C publication Critical patent/CN1079236C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
CN96195992A 1995-08-02 1996-08-02 含阴离子交换树脂的片剂 Expired - Fee Related CN1079236C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22692695 1995-08-02
JP226926/95 1995-08-02

Publications (2)

Publication Number Publication Date
CN1192150A CN1192150A (zh) 1998-09-02
CN1079236C true CN1079236C (zh) 2002-02-20

Family

ID=16852774

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96195992A Expired - Fee Related CN1079236C (zh) 1995-08-02 1996-08-02 含阴离子交换树脂的片剂

Country Status (13)

Country Link
US (1) US6022533A (https=)
EP (1) EP0878198B1 (https=)
KR (1) KR19990035884A (https=)
CN (1) CN1079236C (https=)
AT (1) ATE212852T1 (https=)
AU (1) AU723249B2 (https=)
CA (1) CA2228472C (https=)
DE (1) DE69619139T2 (https=)
DK (1) DK0878198T3 (https=)
ES (1) ES2170864T3 (https=)
PT (1) PT878198E (https=)
TW (1) TW438608B (https=)
WO (1) WO1997004789A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
WO1998039415A1 (en) 1997-03-05 1998-09-11 Japan Science And Technology Corporation Established microglia
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
EP1051977A1 (en) * 1997-11-10 2000-11-15 Hisamitsu Pharmaceutical Co., Inc. Release-sustaining agent for drugs and sustained-release pharmaceutical composition
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
KR100774014B1 (ko) * 2000-05-19 2007-11-08 오츠카 세이야쿠 가부시키가이샤 헬리코박터 파이로리 감염의 진단용 제제
US7201891B1 (en) 2000-05-19 2007-04-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
AU2004285450B2 (en) * 2003-10-20 2010-01-14 Gregory K. Frykman Zeolite molecular sieves for the removal of toxins
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2007031407A (ja) * 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
EP2016114A2 (en) * 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
US20100124542A1 (en) * 2006-07-18 2010-05-20 Genzyme Corporation Amine dendrimers
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) * 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
JP2010519298A (ja) * 2007-02-23 2010-06-03 ゲンズイメ コーポレーション アミンポリマー組成物
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
US20100166696A1 (en) * 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
EP2217215A1 (en) * 2007-12-14 2010-08-18 Genzyme Corporation Coated pharmaceutical compositions
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
CA3203975A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
CA3216359A1 (en) 2021-04-07 2022-10-13 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
AU2024353375A1 (en) 2023-09-29 2026-04-09 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021230A2 (en) * 1979-06-21 1981-01-07 Landstingens Inköpscentral LIC ekonomisk förening An agent for preventing or treating infections in human beings and animals
EP0622078A1 (en) * 1992-01-14 1994-11-02 Hisamitsu Pharmaceutical Co., Inc. Cholesterol level depressant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172324A (ja) * 1987-12-15 1989-07-07 Armour Internatl Co コレスチラミン組成物及びその製造法
US5178854A (en) * 1988-03-24 1993-01-12 Taisho Pharmaceutical Co., Ltd. Cholesterol-lowering agents
US4959219A (en) * 1988-08-15 1990-09-25 Fisons Corporation Coating barriers comprising ethyl cellulose
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
JPH02286621A (ja) * 1989-04-26 1990-11-26 Mitsubishi Kasei Corp 経口コレステロール低下剤
DE4121127A1 (de) * 1991-06-26 1993-01-14 Rettenmaier & Soehne Gmbh & Co Hilfsstoff zur trockenen direkttablettierung und verfahren zur herstellung desselben
US5800809A (en) * 1992-01-14 1998-09-01 Hisamitsu Pharmaceutical Co, Inc Non-crosslinked acrylic polymers and non-crosslinked anion exchange resins
JP3552285B2 (ja) * 1993-08-03 2004-08-11 三菱化学株式会社 経口コレステロール低下剤
US5709880A (en) * 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021230A2 (en) * 1979-06-21 1981-01-07 Landstingens Inköpscentral LIC ekonomisk förening An agent for preventing or treating infections in human beings and animals
EP0622078A1 (en) * 1992-01-14 1994-11-02 Hisamitsu Pharmaceutical Co., Inc. Cholesterol level depressant

Also Published As

Publication number Publication date
EP0878198A1 (en) 1998-11-18
ES2170864T3 (es) 2002-08-16
AU6630596A (en) 1997-02-26
HK1012849A1 (en) 1999-08-13
KR19990035884A (ko) 1999-05-25
DK0878198T3 (da) 2002-04-22
EP0878198B1 (en) 2002-02-06
DE69619139T2 (de) 2002-10-31
CA2228472C (en) 2003-06-17
AU723249B2 (en) 2000-08-24
WO1997004789A1 (en) 1997-02-13
CA2228472A1 (en) 1997-02-13
US6022533A (en) 2000-02-08
CN1192150A (zh) 1998-09-02
PT878198E (pt) 2002-06-28
TW438608B (en) 2001-06-07
EP0878198A4 (https=) 1998-11-18
DE69619139D1 (de) 2002-03-21
ATE212852T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
CN1079236C (zh) 含阴离子交换树脂的片剂
CN1111404C (zh) 控释的羟丁宁制剂
CN1103643C (zh) 基于糊精的涂膜及涂膜组合物
CN1103587C (zh) 可压缩的酶粉
CN1176956C (zh) 包含乙烯酯和聚醚的聚合物的硬胶囊、其用途和生产方法
CN1223341C (zh) 球形体、其制备方法以及药物组合物
CN1228043C (zh) 用于高溶解度药物的缓释基质
CN1111413C (zh) 含阴离子交换树脂的片剂
CN1929821A (zh) 包含匹莫苯的药物组合物
CN1292696A (zh) 组合物
CN1292692A (zh) 含福斯高林衍生物的口服制剂及制备药物制剂的方法
CN1446535A (zh) 盐酸[R－(Z)]－α－甲氧亚氨基－α－(1－氮杂双环[2.2.2]辛－3－基)乙腈控释剂型
CN1321084A (zh) 含有布洛芬和多潘立酮的药用组合物
CN1041104A (zh) 控制释放治疗系统的液体药用制剂的制备方法
CN1607943A (zh) 可控制结合型雌激素天然混合物的释放的基质－膜衣片剂
CN1762357A (zh) 一种莫西沙星口服药物制剂及其制备方法
CN1169523C (zh) 枸橼酸他莫昔芬缓释片
CN1264520C (zh) 一种阿奇霉素肠溶制剂及其制备方法
CN1891218A (zh) 盐酸雷诺嗪缓释制剂及其制备方法
CN1823805A (zh) 一种地红霉素肠溶微丸及制备方法
CN1780606A (zh) 贝特类片剂及其制备方法
CN1698594A (zh) 硫普罗宁的缓释制剂
CN1781479A (zh) 一种马蔺子素分散体系及其制备方法
CN1839814A (zh) 甲硫氨酸肠溶制剂及其制备方法
CN1857288A (zh) 一种复方甘草酸及其盐的缓释制剂及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1050923

Country of ref document: HK